GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neovacs SA (STU:0LW) » Definitions » Other Current Liabilities

Neovacs (STU:0LW) Other Current Liabilities : €1.06 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Neovacs Other Current Liabilities?

Neovacs's other current liabilities for the quarter that ended in Dec. 2024 was €1.06 Mil.

Neovacs's quarterly other current liabilities declined from Dec. 2023 (€0.11 Mil) to Jun. 2024 (€0.03 Mil) but then increased from Jun. 2024 (€0.03 Mil) to Dec. 2024 (€1.06 Mil).

Neovacs's annual other current liabilities declined from Dec. 2022 (€0.59 Mil) to Dec. 2023 (€0.11 Mil) but then increased from Dec. 2023 (€0.11 Mil) to Dec. 2024 (€1.06 Mil).


Neovacs Other Current Liabilities Historical Data

The historical data trend for Neovacs's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovacs Other Current Liabilities Chart

Neovacs Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 1.47 0.59 0.11 1.06

Neovacs Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.57 0.11 0.03 1.06

Neovacs Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Neovacs Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Neovacs's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Neovacs Business Description

Industry
Traded in Other Exchanges
Address
3-5, Impasse Reille, Paris, FRA, 75014
Neovacs SA is a biotechnology company focused on the development of "Kinoids", therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.

Neovacs Headlines

No Headlines